# Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS

> **NCT07225231** · NA · NOT_YET_RECRUITING · sponsor: **Byteflies** · enrollment: 20 (estimated)

## Conditions studied

- Dravet Syndrome (DS)
- Lennox Gastaut Syndrome (LGS)

## Interventions

- **DEVICE:** Byteflies Remote patient monitoring solution (with reduced EEG)

## Key facts

- **NCT ID:** NCT07225231
- **Lead sponsor:** Byteflies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07225231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07225231, "Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07225231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*